Insider Trading June 22, 2026 05:10 PM

Core Molding Technologies Director Sells $60,172 in Shares Amid Strategic Shift

Thomas R. Cellitti's recent divestment coincides with leadership transition and mixed Q1 earnings results.

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
CMT

Thomas R. Cellitti, a director at Core Molding Technologies Inc. (NASDAQ:CMT), executed a sale of the company's common stock totaling $60,172 over two days in mid-June 2026. The transaction follows a period of strong stock performance and occurs alongside significant corporate developments, including a planned CEO transition and recent quarterly financial results that showed mixed outcomes for the manufacturer.

Core Molding Technologies Director Sells $60,172 in Shares Amid Strategic Shift
CMT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Thomas R. Cellitti sold $60,172 worth of CMT shares in mid-June 2026, reducing his direct holdings to 93,806 shares.
  • Core Molding Technologies reported Q1 2026 results with a 23.33% EPS surprise but an 8.69% revenue miss, highlighting mixed operational performance.
  • The company is undergoing a planned CEO transition with David L. Duvall stepping down while remaining in an advisory role through late 2027.

Thomas R. Cellitti, serving as a director at Core Molding Technologies Inc. (NASDAQ:CMT), has completed a transaction involving the sale of company shares valued at $60,172. The disposal of stock took place across two consecutive days in June 2026, with execution prices hovering tightly between $24.00 and $24.0017 per share.

On June 17, 2026, Cellitti offloaded 2,495 shares at a weighted average price of $24.0017. These specific shares were liquidated through multiple transactions, with individual sale prices ranging from $24.00 to $24.03. The following day, June 18, 2026, Cellitti completed a secondary sale of 12 shares at exactly $24.00 per share.

Following these divestments, Cellitti's direct holding in Core Molding Technologies common stock stands at 93,806 shares. The insider sale occurs against a backdrop of notable stock performance for CMT. Over the past year, the shares have delivered a price return of nearly 45%. Despite this strong recent trajectory, analysis from InvestingPro suggests the stock remains undervalued relative to its calculated Fair Value.

Core Molding Technologies currently maintains a market capitalization of $199.78 million and trades at a price-to-earnings (P/E) ratio of 21.11. The company recently reported its first-quarter 2026 earnings, presenting a mixed financial picture. Earnings per share (EPS) came in at $0.37, surpassing the forecasted $0.30, resulting in a positive surprise of 23.33%. However, revenue fell short of expectations, reporting $58.6 million against the anticipated $64.18 million, marking an 8.69% miss.

Simultaneously, Core Molding Technologies announced a planned leadership transition. Current President and CEO David L. Duvall is set to retire, with the transition agreement effective June 1, 2026. Duvall will remain with the company as a part-time employee through December 31, 2027, to provide advisory support. Additionally, the company held its annual meeting of stockholders, where all four proposals presented were approved. During this meeting, 7,671,210 shares were present or represented by proxy, establishing a quorum.

Risks

  • The revenue miss in Q1 2026 indicates potential challenges in sales execution or demand forecasting within the manufacturing sector.
  • The leadership transition may introduce operational uncertainties as the company adapts to new executive direction.
  • Despite strong stock performance, valuation metrics suggest the stock may be undervalued, reflecting market skepticism about future growth or profitability.

More from Insider Trading

Trulieve CEO Kim Rivers Executes $4.53 Million Share Sale Under Pre-Approved Plan Jun 22, 2026 Kura Oncology CMO Mollie Leoni Disposes of $834K in Shares Under Pre-Arranged Plan Jun 22, 2026 Grocery Outlet Executive Miller Acquires $93,699 in Company Shares Jun 22, 2026 Walmart Executive VP Nicholas James Executes $342,752 Stock Sale Under Pre-Arranged Trading Plan Jun 22, 2026 Kymera Therapeutics CBO Noah Goodman Executes $247,500 Stock Sale Under Pre-Arranged Plan Jun 22, 2026